Amrize (NYSE:AMRZ) Price Target Lowered to $42.00 at UBS Group

Amrize (NYSE:AMRZ) had its price target dropped by stock analysts at UBS Group from $57.00 to $42.00 in a research report issued on Tuesday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s price target indicates a potential upside of 7.59% from the company’s previous close.

Several other research firms have also recently commented on AMRZ. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Amrize in a research note on Friday, June 26th. DA Davidson assumed coverage on Amrize in a report on Monday, August 24th. They issued a “neutral” rating and a $50.00 price target for the company. Sanford C. Bernstein reissued an “outperform” rating and issued a $60.00 price target on shares of Amrize in a research note on Monday. JPMorgan Chase & Co. downgraded Amrize from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $57.00 to $52.00 in a research note on Wednesday, September 2nd. Finally, Zacks Research downgraded Amrize from a “hold” rating to a “strong sell” rating in a research note on Wednesday, August 19th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eight have issued a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, Amrize presently has a consensus rating of “Hold” and an average price target of $53.31.

Amrize Trading Up 1.2%

Shares of NYSE:AMRZ traded up $0.45 during midday trading on Tuesday, reaching $39.04. The company had a trading volume of 1,081,105 shares, compared to its average volume of 3,344,158. The company has a fifty day simple moving average of $45.77 and a two-hundred day simple moving average of $51.38. The firm has a market cap of $21.59 billion, a price-to-earnings ratio of 18.02, a price-to-earnings-growth ratio of 1.16 and a beta of 0.04. Amrize has a 1-year low of $37.38 and a 1-year high of $65.94. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10.

Amrize (NYSE:AMRZ) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The firm had revenue of $3.49 billion for the quarter. Research analysts predict that Amrize will post 2.57 earnings per share for the current year.

Insider Transactions at Amrize

In other Amrize news, CEO Jan Jenisch bought 26,000 shares of Amrize stock in a transaction dated Wednesday, September 2nd. The stock was bought at an average cost of $42.47 per share, with a total value of $1,104,220.00. Following the completion of the acquisition, the chief executive officer directly owned 1,767,000 shares in the company, valued at approximately $75,044,490. The trade was a 1.49% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Mario Gross bought 3,568 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was bought at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the purchase, the insider owned 38,485 shares of the company’s stock, valued at approximately $1,793,401. The trade was a 10.22% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders have acquired 48,983 shares of company stock worth $2,158,755. Company insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Norges Bank bought a new stake in Amrize in the 4th quarter worth $929,333,000. Geode Capital Management LLC raised its stake in Amrize by 3.4% during the 4th quarter. Geode Capital Management LLC now owns 6,093,012 shares of the company’s stock worth $328,080,000 after acquiring an additional 198,810 shares during the period. Pictet Asset Management Holding SA boosted its holdings in Amrize by 4.7% in the 1st quarter. Pictet Asset Management Holding SA now owns 5,216,765 shares of the company’s stock worth $283,017,000 after buying an additional 234,731 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in shares of Amrize by 3.7% in the first quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company’s stock worth $263,371,000 after acquiring an additional 171,622 shares during the period. Finally, Barclays PLC raised its position in shares of Amrize by 95.4% during the fourth quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock valued at $249,557,000 after buying an additional 2,253,431 shares during the last quarter.

About Amrize

Amrize is a North American building materials and solutions company formed through the separation of Holcim’s North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.